These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9514405)

  • 1. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.
    Torzewski M; Klouche M; Hock J; Messner M; Dorweiler B; Torzewski J; Gabbert HE; Bhakdi S
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):369-78. PubMed ID: 9514405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An alternative hypothesis of the pathogenesis of atherosclerosis].
    Bhakdi S
    Herz; 1998 May; 23(3):163-7. PubMed ID: 9646097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety.
    Bhakdi S; Dorweiler B; Kirchmann R; Torzewski J; Weise E; Tranum-Jensen J; Walev I; Wieland E
    J Exp Med; 1995 Dec; 182(6):1959-71. PubMed ID: 7500042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis.
    Torzewski M; Suriyaphol P; Paprotka K; Spath L; Ochsenhirt V; Schmitt A; Han SR; Husmann M; Gerl VB; Bhakdi S; Lackner KJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2130-6. PubMed ID: 15345515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation.
    Bhakdi S; Torzewski M; Klouche M; Hemmes M
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2348-54. PubMed ID: 10521363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
    Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.
    Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S; Itabe H; Takano T
    Atherosclerosis; 1998 Nov; 141(1):61-75. PubMed ID: 9863539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.
    Torzewski J; Torzewski M; Bowyer DE; Fröhlich M; Koenig W; Waltenberger J; Fitzsimmons C; Hombach V
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1386-92. PubMed ID: 9743226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
    Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.
    Itabe H; Takeshima E; Iwasaki H; Kimura J; Yoshida Y; Imanaka T; Takano T
    J Biol Chem; 1994 May; 269(21):15274-9. PubMed ID: 8195164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.
    Hakala JK; Oksjoki R; Laine P; Du H; Grabowski GA; Kovanen PT; Pentikäinen MO
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1430-6. PubMed ID: 12750117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
    Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
    J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptors in atherosclerotic lesions.
    Saito E; Fujioka T; Kanno H; Hata E; Ueno T; Matsumoto T; Takahashi Y; Tochihara T; Yasugi T
    Artery; 1992; 19(1):47-62. PubMed ID: 1531410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody.
    Kim JG; Taylor WR; Parthasarathy S
    Atherosclerosis; 1999 Apr; 143(2):335-40. PubMed ID: 10217362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and atherogenesis: the unknown connection.
    Bhakdi S
    Ann Med; 1998 Dec; 30(6):503-7. PubMed ID: 9920350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
    Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
    Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro.
    Oörni K; Sneck M; Brömme D; Pentikäinen MO; Lindstedt KA; Mäyränpää M; Aitio H; Kovanen PT
    J Biol Chem; 2004 Aug; 279(33):34776-84. PubMed ID: 15184381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation by oxidatively modified low-density lipoproteins.
    Wieland E; Dorweiler B; Bonitz U; Lieser S; Walev I; Bhakdi S
    Eur J Clin Invest; 1999 Oct; 29(10):835-41. PubMed ID: 10583425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution and quantification of oxidative low density lipoprotein in the development of atherosclerotic lesions of human aorta].
    Mao Z; Lou D
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):224-7. PubMed ID: 9275657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions.
    Kataoka H; Kume N; Miyamoto S; Minami M; Moriwaki H; Murase T; Sawamura T; Masaki T; Hashimoto N; Kita T
    Circulation; 1999 Jun; 99(24):3110-7. PubMed ID: 10377073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.